Expanded access, sometimes called “compassionate use,” is the use of an investigational medicine (i.e., one that has not been approved by the Food and Drug Administration (FDA) by a patient who can not be enrolled in a clinical trial. Please see Veralox Therapeutic’s Expanded Access Policy here.